Aug. 1, 2016

Navy Needs to Establish Effective Metrics to Achieve Desired Outcomes for SPY-1 Radar Sustainment (Redacted) DODIG-2016-116

We determined whether the performance metrics included in the Navy’s AN/SPY-1 Phased Array Radar (SPY-1 radar) performance-based logistics contracts appropriately incentivized the support contractors. This audit is the second in a series on SPY-1 radar spare parts.

July 29, 2016

Marine Corps Installations National Capital Region-Regional Contracting Office Generally Implemented Recommendations

We determined whether the Marine Corps Regional Contracting Office–National Capital Region implemented the recommendations in Report No. DODIG-2015-095, “Small Business Contracting at Regional Contracting Office–National Capital Region Needs Improvement,” March 20, 2015. On October 6, 2015, the Marine Corps Regional Contracting Office–National Capital Region was renamed as Marine Corps Installations National Capital Region–Regional Contracting Office (MCINCR-RCO). We will use the new name throughout the report.

July 26, 2016

Army General Fund Adjustments Not Adequately Documented or Supported

We determined whether adjustments made to Army General Fund (AGF) data during the FY 2015 financial statement compilation process were adequately documented and supported. In addition, we assessed the internal controls over the compilation process.

July 26, 2016

Actions Needed to Improve the Marine Corps, Navy, and Air Force Reporting of Operating Materials and Supplies

We determined whether the Operating Materials and Supplies (OM&S)–Ammunition owned by the Marine Corps, Navy, and Air Force (the other Services) and held by the Army was accurately reported on each Service’s respective financial statements.

July 26, 2016

U.S. Army Central Support Element-Jordan Did Not Implement Controls to Effectively Maintain Facilities at the Joint Training Center-Jordan DODIG-2016-115

Our objective was to determine whether DoD is effectively maintaining facilities at the Joint Training Center (JTC)–Jordan. JTC is a contingency base occupied by elements of the Jordanian Armed Forces (JAF) and Allied partners. There are two types of U.S.-occupied facilities on JTC: JAF-owned facilities and U.S.-built facilities. The U.S. Army Central Support Element–Jordan (ASE-J) pays a monthly utilization fee for the use of the JAF-owned facilities. In March 2016, the ASE-J and JAF entered into an Implementing Arrangement (IA) to the U.S.-Jordan Acquisition and Cross-Servicing Agreement, which outlined reimbursement for maintenance performed by the JAF for the JAF-owned, U.S.-occupied facilities. However, ASE-J personnel stated the IA did not require JAF to provide maintenance to U.S.-built facilities on JTC.

July 25, 2016

Army Officials Did Not Consistently Comply With Requirements for Assessing Contractor Performance DODIG-2016-112

We determined whether Army officials completed comprehensive and timely contractor performance assessment reports (PARs) for nonsystems contracts as required by Federal and DoD policies. This is the third in a series of audits on DoD compliance with policies for evaluating contractor performance.

July 12, 2016

Army Needs Greater Emphasis on Inventory Valuation

We determined whether the Department of the Army properly records Army Working Capital Fund (AWCF) Inventory, Available and Purchased for Resale, at moving average cost (MAC1) within the Logistics Modernization Program (LMP2) system.

July 6, 2016

Advanced Arresting Gear Program Exceeded Cost and Schedule Baselines (Redacted)

Our objective was to determine whether the Navy was effectively managing the acquisition requirements and testing for the Advanced Arresting Gear (AAG) program. The arresting gear is the system responsible for stopping aircraft while landing on the flight deck of a carrier.

July 1, 2016

Controls Over Compound Drugs at the Defense Health Agency Reduced Costs Substantially, but Improvements Are Needed

Our objective was to determine whether the Defense Health Agency (DHA) implemented adequate controls over payments for compound drugs.